Morgan Stanley’s Shockwave Medical SWAV Stock Holding History
Bought
Maintained
Sold
Other funds holding SWAV
Morgan Stanley's SWAV Position: Q2 2024 in Review
Morgan Stanley sold out of Shockwave Medical (SWAV) in Q2 2024, closing a stake of 446,611 shares — an estimated $145M sold.
Morgan Stanley first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $145M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.
- Morgan Stanley reported no remaining Shockwave Medical position as of Q2 2024 after selling out during the quarter.
- Morgan Stanley sold 446,611 Shockwave Medical shares in Q2 2024, an estimated $145M.
- Morgan Stanley first reported a position in Shockwave Medical in Q1 2019 and held it in 21 quarters.
- Morgan Stanley's Shockwave Medical position peaked at $145M in Q1 2024.
- 7 funds tracked by Wall St. Rank held Shockwave Medical as of Q2 2024.
Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.